Risk factors | Relapse | OS | DFS | GRFS | ||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate (P (HR, 95% CI)) | Univariate | Multivariate (P (HR, 95% CI)) | Univariate | Multivariate (P (HR, 95% CI)) | Univariate | Multivariate (P (HR, 95% CI)) | |
Female vs male | NS | NS | NS | NS | NS | NS | NS | NS |
Patient age, ≥33 vs <33 years | NS | NS | NS | NS | NS | NS | NS | P = 0.039 (2.02, 1.07–3.8) |
ALL vs AML | NS | NS | NS | NS | NS | NS | NS | NS |
High risk vs standard risk | NS | NS | NS | NS | P = 0.03 | P = 0.028 (2.31, 1.09–4.87) | NS | P = 0.018 (2.14, 1.14–4.02) |
G-PBSC vs G-BM | NS | NS | NS | NS | NS | NS | P = 0.03 | P = 0.071 (1.82, 0.95–3.49) |
CD3+ T, ≥166 × 106 vs <166 × 106 cells/kg | NS | NS | NS | NS | NS | NS | NS | NS |
Treg, <5.2 × 106 vs ≥5.2 × 106 cells/kg | NS | NS | NS | NS | NS | NS | NS | NS |
MDSCs, <3.65 × 106 vs ≥3.65 × 106 cells/kg | NS | NS | NS | NS | NS | NS | P < 0.001 | P < 0.001 (3.49,1.77–6.90) |